Assessment of comorbidities in COPD patients by chest HRCT

<bold>Background and objective:</bold> COPD is a progressive respiratory condition often accompanied by various comorbidities that significantly affect patient outcomes. HRCT imaging has emerged as a valuable tool for diagnosing and managing COPD-related comorbidities. This study aims to explore the impact of chest CT imaging in identifying and characterizing comorbidities in COPD patients. <bold>Methods:</bold> The study was conducted on 99 patients with COPD, with an average age of 67,8 (37-88), 85% were men (85), and 14% were women (14). The patients underwent chest computed tomography to identify the presence of imaging comorbidities. <bold>Results:</bold> According to the GOLD classification, ABE type, 3% were type A, 27% were type B, and 69% were type E. The prevalence of comorbidities identified on chest HRCT was reported as 66% for coronary artery calcification, 83% for osteoporosis, 36% for pulmonary artery enlargement, 31% for emphysema, 19% for bronchiectasis, 17% for hiatal hernia, 14% for lung cancer, 12% pulmonary infections and 3% for interstitial abnormalities. In 4% there were no comorbidities, one comorbidity was found in 11%, two comorbidities in 17%, and three comorbidities and more in 68% of cases. <bold>Conclusion:</bold> Chest CT imaging serves as a valuable tool for identifying and assessing comorbidities in patients with COPD. Incorporating chest CT imaging into the routine evaluation of COPD patients can contribute to a more comprehensive understanding of their condition and lead to better clinical outcomes. KEYWORDS COPD, comorbidities, chest HRCT, chest computed tomography